You have 9 free searches left this month | for more free features.

Immunomodulatory Agents

Showing 1 - 25 of 6,024

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatic Diseases Trial in Ciudad Autónoma de Buenos Aires (Immunosuppressive Agents)

Completed
  • Rheumatic Diseases
  • Immunosuppressive Agents
  • Ciudad Autónoma de Buenos Aires, Caba, Argentina
    Sociedad Argentina de Reumatología
Jan 30, 2023

Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

Completed
  • Relapse/Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +16 more
Jul 27, 2022

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Acute Myeloid Leukemia Trial in United States (Atezolizumab, Guadecitabine)

Completed
  • Acute Myeloid Leukemia
  • Duarte, California
  • +7 more
Mar 11, 2020

Sepsis, Septic Shock, Immunoinflammatory Response Trial in Tunis (Erythromycin)

Recruiting
  • Sepsis
  • +2 more
  • Tunis, Tunisia
    intensive care unit of the University Hospital Center La Rabta
Apr 26, 2022

CIPN and it's Impact on Quality of Life in Patients Receiving

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
    • (no location specified)
    Apr 24, 2023

    Uveitis With Biologic Drugs in Resistant Cases

    Not yet recruiting
    • Uveitis
    • Biologic drugs
    • (no location specified)
    Apr 21, 2022

    COVID-19 Trial in Assiut (Licorice extract)

    Completed
    • COVID-19
    • Licorice extract
    • Assiut, Egypt
      Faculty of Medicine, Assiut University
    Mar 21, 2022

    Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)

    Active, not recruiting
    • Multiple Myeloma
    • panobinostat capsules
    • +2 more
    • Fayetteville, Arkansas
    • +79 more
    Mar 15, 2021

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)

    Not yet recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • (no location specified)
    Jun 8, 2023

    Triple Negative Breast Cancer, Non Small Cell Lung Cancer, Metastatic Breast Cancer Trial in United States (Stereotactic Body

    Recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Stereotactic Body Radiotherapy/SBRT
    • Systemic Therapy/Standard of Care
    • Hartford, Connecticut
    • +11 more
    Aug 24, 2022

    Primary Sjögren's Syndrome (pSS) Trial in Le Kremlin-Bicêtre (Hydroxychloroquine 400mg/d, Leflunomide 20mg/d, Mycophenolate

    Recruiting
    • Primary Sjögren's Syndrome (pSS)
    • Hydroxychloroquine 400mg/d
    • +5 more
    • Le Kremlin-Bicêtre, France
      Raphaele Seror
    May 2, 2022

    Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

    Terminated
    • Multiple Myeloma
    • Milano, Italy
    • +10 more
    Jul 4, 2022

    Metastatic Solid Tumors of Metastatic Disease Trial in United States (Radiation Therapy, Systemic Therapy)

    Recruiting
    • Metastatic Solid Tumors of Metastatic Disease
    • Radiation Therapy
    • Systemic Therapy
    • Miami, Florida
    • +8 more
    Dec 6, 2022

    Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • 18F-fluciclovine injection
    • 18F-FDG PET/CT
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 31, 2023

    Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

    Recruiting
    • Plasma Cell Myeloma
    • +3 more
    • Bone Marrow Biopsy
    • +3 more
    • Phoenix, Arizona
    • +2 more
    Jan 18, 2023

    Immune-related Adverse Events Refractory to Standard Therapy and

    Recruiting
    • Immune-related Adverse Event
    • Extracorporeal photopheresis
    • Other immunosuppressive or immunomodulatory drugs
    • Munich, Germany
      LMU Klinikum Hauttumorzentrum
    Jan 17, 2023

    Unresectable Colorectal Liver Metastases Trial in Boulogne-Billancourt (Chemotherapy, Radiofrequency ablation (RFA), In situ

    Not yet recruiting
    • Unresectable Colorectal Liver Metastases
    • Boulogne-Billancourt, France
      Digestive Surgery Department, Ambroise Pare University Hospital,
    Jun 14, 2021

    Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia Trial in Minsk (Vaccination with pneumococcal conjugate vaccine

    Enrolling by invitation
    • Multiple Myeloma
    • +3 more
    • Vaccination with pneumococcal conjugate vaccine (PCV13)
    • Standard Antibacterial Prophylaxis
    • Minsk, Belarus
      Minsk Scientific Practical Center of Surgery, Transplantation an
    Sep 1, 2020

    Juvenile Idiopathic Arthritis Trial in Cairo (dietary supplement, other, drug)

    Recruiting
    • Juvenile Idiopathic Arthritis
    • Coenzyme Q10
    • +2 more
    • Cairo, Egypt
      Pediatric Allergy, Immunology, Rheumatology Clinic, Children's H
    May 27, 2023

    Critical Illness Trial in Mansoura (Lactoferrin)

    Not yet recruiting
    • Critical Illness
    • Mansoura, El-dakhlia, Egypt
      Mansoura University hospital
    Jul 6, 2023

    Advanced HCC Trial (Lenalidomide)

    Not yet recruiting
    • Advanced HCC
    • (no location specified)
    Apr 16, 2023

    HIV Trial in Pittsburgh (Ampligen)

    Completed
    • HIV Infections
    • Pittsburgh, Pennsylvania
      Univ of Pittsburgh Med School
    Oct 27, 2021

    Immune Response in Hypersensitivity Pneumonitis

    Completed
    • Hypersensitivity Pneumonitis
    • Bronchoscopy with lavage
    • Iowa City, Iowa
      University of Iowa
    May 16, 2022